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Introduction 
Allergic dermatitis is a disorder of the skin 
manifested by an inflammation upon exposure to a specific 
antigenic substance for which the individual has acquired 
an hypersensitivity. This type of reaction has been 
described in the literature under various names such as 
eczematous sensitization, contact dermatitis of the allergic 
type, contact allergy, dermatitis venenata, allergic 
sensitization, and allergic eczematous hypersensitivity. 
Nevertheless, the names all refer to one condition 
(hereafter called allergic dermatitis in this paper) which 
has several distinguishing characteristics. There 
must be a period of time after exposure of the skin to 
a specific allergen during wluch the individual becomes 
sensitized (usually ten to fourteen days). After 
sensitization, the individual may be made to ~eact upon 
application of the specific allergen (or, in some instances, 
a chemically rel~ted material). The entire area of the 
skin is hypersensitive although sensitization may have 
occurred by application of the allergen to a defined 
area. The reaction is of the delayed hypersensitive 
type with the appearance of lesions on a previously 
sensitized individual occurring several hours, usually 
betv1een ti·renty-four and forty-eight, after exposure to the 
allergen. There is no evidence that this type of sensitivity 
is inherited as in atopy. The lesion consists of a marked 
inflammation of the skin usually vri th vesicle formation. 
Co 
Apparently, the main shock tissue is the skin. 
Extensive research has been carried out in an effort 
to discover the mechanism of sensitization in allergic 
dermatitis. The literature reveals a large volume of 
information gained from these in~estigations. Yet, a 
great deal is still to be proven in order to gain a 
comprehensive insight of the cause, method of spread and 
the reaction presented by this type of hypersensitivity. 
Experimentation of this type is very important because 
a complete understanding of the mechanism of sensitization 
is a basis for formulating methods of prophylaxis and 
treatment. At the present time, little can be done to 
prevent immunologically the sensitization of an individual, 
and treatment, for the most part, consists of alleviation 
of the distress of the inflammed, vesiculated tissue. 
With the industrial production of large numbers of 
synthetic products, the number of c~ses of allergic 
dermatitis increases. As a result, there is an increasing 
necessity for full understanding of the problems associated 
with the sensitive state. Indeed, it has been said that 
allergic dermatitis is a disease of civilization. 
The purpose of this paper is to present the various 
a.spects of allergic dermatitis which are associated "'vi th 
the mechanism of sensitization. 
Factors Influencing the Incidence of Sensitization 
In 1895, Jadassohn (1) was the first to recognize that 
certain drugs were capable of producing allergic reactions 
of the skin. Following this, in 1920, one of the first 
to recognize the patch test as a specific diagnostic 
tool was Markley (2) who demonstrated a marked reaction 
to guinea pig hair taped to the side of the neck of an 
hypersensitive subject. Since this time, the patch test 
has been used widely to detect sensitivity of the skin 
to specific allergens in populations. 
Spain (3) utilized the patch test to a great extent, 
actually bringing the term "patch test 11 into common 
usage, in demonstrating that an hypersensitive reaction 
did not occur on first exposure to the antigen. He tested 
eighteen infants and found that none of them ahowed 
positive patch tests to poison ivy extract, yet 65 per cent 
of patients over eight years old were sensitive to the 
extract. Furthermore, he pointed out that sensitive 
indivrduals reacted at a delayed time after exposure to 
the allergen. This led him to suggest that ttie reactions 
from patch tests should be sought for a period of at 
least ten days after ~he test was done. In 1929, Bloch (4) 
recognized that individuals sensitive to specific agents 
had a history of previous exposure. Classical proof 
that prior sensitization vras necessary before an hyper-
sensitive reaction occurred on contact 1-ri th the antigen 
was offered in 1931 by Straus (5). He found that of 
119 newborn inf~nts, none were sensitive to poison ivy 
extract when patch tested. Later, 48 of the same infants 
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were r•etested and 72.9 per cent showed positive patch 
tests. Control studies were d~ne on 41 normal adults 
which resulted in 75.6 per cent positive reactors to 
the same patch tests. His work also pointed out the 
~act that this.type of hypersensitivity is not an in-
herited one since all of the newborn infants were not 
sensitive. 
Of the population tested by Spain, Newell and 
Meeker (6) in 1934, twenty-seven per cent shov.red positive 
skin tests to a l:lOO dilution of an extract of poison 
ivy and ~wenty-four per cent showed a positive reaction 
to poison oak extract. Further population studies were 
carried out by Knowles et al (7) who test~d~l04 and 119 
male medical students at two different times and found 
40.4 per cent and 49.6 per cent positive reactors to a 
_ five per cent extract of poison ivy leaves, respectively. 
Grolnick (8) was able to sensitize 86.3 per cent of 
37 patients by placing one or several applications of 
krameria to the skin. Later, Kanof and Rostenberg (9) 
reported an incidence o~ twenty-~iv~ per cent positive 
skin reactors to a dilution of 1:100 of poison ivy extract 
in a group of 48 people. 
The various ~igures of incidence of skin reactivity 
to allergens were not consistent because of many factors 
(such as the nature of the allergen, the concentration of 
the allergen, the patient, the age of the patient, etc.). 
Some of these ~actors have undergone extensive investigation 
since an understanding of why people react differently to 
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specific substances would be a major advance toward a 
complete knowledge of the mechanism of the sensitization. 
It has been sho1tm the.t the incidence of sensitive 
individuals to allergic dermatitis increases with age 
to adulthood and then decreases as age increases. As 
stated above, the incidence of sensitivity _of newborn 
infants is zero. Coca (10) tested twelve people under 
six y~ars of age for sensitivity to poison ivy and found 
that only one individual was sensitive. He also patch 
tested twelve people over twenty years old with the same 
extract and found that eleven of them were sensitive. 
In the group of people tested by Kanof and Rostenberg (9), 
the average age was 44.5 years and the incidence of 
sensitivity to a dilution of 1:100 poison ivy extract 
was twenty-five per cent. Kligman (11) has reported 
studies of sensitivity to poison ivy and recorded the 
incidence according to age group as follows: 
Age of person 
21-30 
31-40 
41-50 
51-60 
61-70 
Per cent of people sensitive 
58 
1~7 
41 
32 
14 
It "\vas his opinion _that this decline in sensitivity was 
not coincident with a decline in exposure. Evidently, 
people who had received repeated exposures to the specific 
4IJ allergens did not demonstrate a lower threshold of 
sensitivity. In Kligman's vmrds, there vras no "booster effect" 
to sensitivity by increased exposure to the allergen. 
b. 
In early years of experimental investigation, the 
impression was gained that there was a difference in 
skin sensitiyity among various races. Deibert, Menger 
and Wigglesworth (12) set out to prove this by simultaneously 
patch testing full-blooded American Indians and people 
of the vfuite race to poison i~y extract. They found 
that in 227 indians (between the ages of fourteen and 
twenty-~our years) and in 46 white people tested that 
the incidence of sensitivity was 56 and 58.8 per cent 
respectively. Thus, there was no signi~icant di~ference 
in sensitivity to poison ivy between the races tested. 
This was substantiated by later work (9) demonstrating no 
significant difference between the reactivity of TNhite 
and Negro races. 
It has been mentioned above that allergic dermatitis 
was not an hereditary disease and sensitivity to allergens 
of this type could not be demonstrated in newborn 
infants. It has been recorded (13) that a history of 
familial allergy was just as prevalent among normal 
individuals as among those with allergic dermatitis. 
Furthermore~ in studies conducted by Knowles et al (7) 
on the incidence of susceptibility to poison ivy, there 
was no si~Lificant difference among the sensitive subjects 
whether there was a personal or family history of allergy 
~ or not. However, Chase (14) was able to breed strains 
of guinea pigs of high and low susceptibility to skin 
sensitization with 2-4 dinitrochlorobenzene. 
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Guinea pigs have been widely used as exp~rimental 
animals in sensitivity studies since it was sho~m (15) 
that they could be made sensitive to poison ivy extract. 
However, the typical lesion of allergic dermatitis in 
humans was not the same as that which a~pears in guinea 
pigs. For this reason, Straus (16) sensitized monkeys 
and found that lesions on this &nimal were more like the 
lesions on humans. Fortunately, allergic dermatitis is 
a type of disease in which experimentation on human beings 
is easily done and not extremely uncomfortable for the 
patient. 
Another factor which has been found to influence 
the ability of the animal to become sensitized was a 
vitamin G deficient diet. It has been shown by Simon (17) 
and confirmed and extended by Kile and Pepple (18) that 
guinea pigs on a vitamin G deficient diet did not become 
sensitized to poison ivy extract to as great an extent as 
other animals on an adequate diet. 
Rostenberg (19) reported on the factors which 
interrelate to produce skin sensitivity. It was his 
opinion that the nature of the allergen, its quantitative 
factors, and the host, the environmental influences on 
the host, and the genetic constitution of the host, 
determine whether or not a particular individual possesses 
~ the capacity to demonstrate allergic dermatitis in any 
given situation. 
8. 
Nature o~ the Allergen 
A great many different substances have been found to 
be sensitizing agents in experimental animals and in man. 
Landsteiner's and Jacobs' (20)(21)(22) classical 
experiments with guinea pigs contributed to the understand-
ing of the nature of substances capable of sensitizing 
individuals. They showed t11at the allergens capable of' 
producing allergic dermatitis could be simple.chemica~ 
compounds. These simple chemical compounds in vivo 
combined firmly with proteins and as a result, acted as 
antigens. They sensiti~ed guinea pigs to 1:2:4 chlor-
dinitrobenzene, paranitrosodimethylaniline, 
1:2:4 trinitrobenzene, picryl chloride and four dichloro-
dinitrobenzenes. Landsteiner ru1d Jacobs, and Landsteiner (23) 
noted that there apneared to be a correlation between 
the sensitizing ability of' a substance and its chemical 
structure. These authors observed that the structures 
which com~only induced sensitivity in animals were 
com:9ounds with label Cl and N02 ions which were easily 
displaced. Thus, the free bonds were able to conjugate 
with the protein producing an antigen. On the other 
hand, they noted that compounds with stable ions were 
not freely displaceable and, therefore, the conjugation 
with protein was not possible. Lanasteiner and his 
collegues formulated the following conclusions to these 
studies: 1. simple compounds could combine or conjugate 
with proteins in vivo to form sensitizing agents, 
' 2. other groups of chemical compounds required alteration 
in structure by metabolic processes'in vivo prior to 
combining v-rith the protein. Specifically~ they showed 
that paraphenylenediamine was 9Xidized then combined in 
firm chemical union with the protein. These conclusions 
were ~upported with additional experimentation by Landsteiner 
and DiSomma (24). 
The original findings of Landsteiner et al, were 
confirmed and extended by several investigators. 
Sulzberger and Baer (25) used several ch~or-nitro 
substituted benzenes as sensitizing agents on human 
subjects. They found that the ce,paci ty to produce allergy 
paralleled the ability of the allergen to form conjugates 
with larger molecules of protein. More recently, Gell (26) 
found that sensitization to trinitrophenylmethylnitramine 
occurred by conjugation with_body protein to form 
the antigenic npicrylprotein". Further substantiation 
of the findings of Landsteiner and Jacobs was the w·ork 
of Zeligman (27) who found that oxidation products of 
paraphenylenediamine were the cause of sensitization 
to paraphenylenediamine. But, compounds structurally 
related to paraphenylenediamine and not oxidized to 
quinhydrone were not sensitizing agents. 
It may be concluded that sensitizing agents react in 
the body in one of three waws: 1. by combination with 
protein as the nit~obenzenes, 2. by conjugation with 
protein only after being altered in some way by metabolism 
10. 
as paraphenylenediamine, or 3· by formation of an 
adsorbed complex with the protein instead of actmal 
chemical union. Thus, simple chemical compounds which 
combine with body protein become antigenic. 
It has been shown (28) that these simple chemicals 
when injected are not, themselves, antigens which provoke 
the normal antibody response. Many investigators have 
studied the routes of inoculation of the sensitizing 
agent in order to e~fect sensitivity. Substances have 
been injected by the intravenous, intraperitoneal (15)(17), 
oral (29) and intramuscular (17) route with no developing 
sensitivity. 
One report has been made by Landsteiner and Chase (30) 
indicating that it was possible to sensitize animals by 
intraperitoneal injection of the allergen. Although 
others have reported this finding, these experiments 
included careful controls to prevent contamination of 
the skin. In this work, sensitization of the· skin 
occurred follovling intraperitoneal injection of picryl 
chloride in an adjuvant of killed tubercle bacilli in 
paraffin oil. 
Following this, Landsteiner and Chase (31) succes~fully 
sensitized the skin of guinea pigs by intraperitoneal 
injection of either picryl chloride or 2:4 dinitro-
~, fluorobenzene conjugated in vitro with homologous 
erythrocyte stromata. 
Haxthausen (32) was able to sensitize the skin of 
humans by intramuscular injection. This was possible 
11. 
only when he mixed serum from.the experimentaf subject 
with the sensitizing agent (dinitrochlorobenzene). 
Because of this, he concluded that sensitizing agetns 
must be coupled to proteins before injection in order 
for routes of inoculation other than the cutaneous 
application of the sensitizing agent to be effective 
in causing skin sensitivity. 
Most workers agree that sensitization of the skin 
occurs most readily by application of the allergen to 
the skin or by intradermal inoculation, although it has 
been established that sensitization by routes other than 
the cutaneous route is possible. In all experiments 
in which sensitization of the skin was effected by 
inoculation of the all.ergen by routes other than 
cutaneous, the allergen was combined with a protein 
before injection. 
Method of Absorption of Allergen from the Skin 
Once the allergen has formed a complex with proteins 
of the skin, the mea,ns by which it is absorbed from the 
skin has been one of the major problems in the mechanism 
of sensitization in allergic dermatitis. Several 
investigators conducted experiments in an effort to 
·determine whether the complex remained in the skin or 
was transported ~o other sites within the body. It was 
thought that this information would give an insight 
into the means by which the skin sensitization becomes 
generalized over the total area of the body. ·Rostenberg (33) 
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~ revie1;red and summarized this 1;-rork. He set down and 
discussed three possible means by which the allergen 
may be absorbed i'rom the skin. First, it vias propos·ed 
that the allergen may be sbsorbed in the same chemical 
state in which it was applied to the skin. By this means, 
the pxotein complexed with the allergen would merely 
act as a trans~rt mechanism to get the allergen across 
the skin barrier and then release the allergen in its 
original chemical state for absorption. This was 
shown not to be the case because, based on vrork cited 
previously, allergens injected directly into the body 
by the intramuscular or intravenous route were nqt 
capable of causing skin sensitization to develop. The 
second possibility was that the allergen was not absorbed 
from the skin at all but remained in the localized 
skin area where it was applied. Also, this has 
been pr~ven not to be true because, removal of the 
. 
sensitized skin area twenty-four hours a,fter application 
oi' the allergen did not prevent development of generalized 
skin sensitivity (17). The third proposal of a means 
in which the allergen is absorbed i'rom the skin is 
the one which is generally accepted (28) and is consistent 
with experimental evidence at the present time. This is 
that the allergen is absorbed i'rom the skin in its 
conjugated form with protein. This is supported by work 
of Landsteiner and Chase (30)(31) and Haxthausen (32), 
who successfully sensitized skin of animals and humans 
by intraperitoneal or intramuscular injections of the 
allergen coupled to a protein. 
It was thought by ·witten and March (34) that perhaps 
something in the skin of sensitive individuals differed 
from the skin of nonsensitive people. This difference 
might be in the manner of absorption of the allergen from 
the skin and, thus, account for the ~evelopment of sensitivity. 
In order to test this hypothesis, they carried out isotope 
studies with c14 labeled dinitrochlorobenzene as an 
allergen in guinea pigs. By measuring the radioactivity, 
they found that the allergen localized in the epidermis 
and occasionally in hair follicles and sweat ducts of the 
skin~ They also showed that the allergen disappeared 
from the skin faster in sensitive than in nonsensitive 
animals. These investigators found a greater quantity 
of radioactivity in the buffy coat of the blood in 
sensitive animals than in nonsensitive animals. The 
results of this report were in contrast to results 
obtained in previous studies carried out by Witten et al (35) 
using radioactive Mercury as an allergen. However, it 
1rrss noted that tp.e· techniques employed in this earlier 
study vtere in error. It was t~~e conclusion of these 
investigators that, since absorption is increased in 
sensitized animals, the skin on preliminary exposure to 
allergens are altered in some manner to render the 
individual allergic to the compound in question. 
However, this concept as a phase in the mechanism of 
0 
0 
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sensitization is yet to be challenged or confirmed by 
other investisators. 
The route of absorption of the complexed allergen 
with protein has been t'1e aubject of m .. unerous experimenta-
tions. As early as 1927, Spain and Cook (36) postulated 
the passage of allergens through the blood and lymph channels 
in order to effect generalized skin sensitivity. Then 
in 1934, Straus (29) performed experiments which Coca 
stated were consistent with the point of view that 
sensitivity was limited to the epidermis and generalized 
skin reactions occurred after local application of poison 
ivy extract by diffusion of the allergen through oily 
substances normally present in the skin. This was con-
firmed later by Straus anO.. ·coca (37) who made an incision 
around the upper part of the arm of the Rhesus monkey 
and peeled the skin of the arm do\~ toward the elbow 
forming a cuff and, thus, separating the epidermis of 
the lower part of the arm from the rest of the skin. 
Sensitization of tl1e skin of the lov.rer part of t~'le arm to 
poison _ivy extract did not cause generalized .skin 
sensitization over the rest of the body. These workers 
stated that since sensitivity did not cross the area 
v.rher.e there :,·ras no epidermis, sensitivity was not due 
to transportation of the allergen by internal body fluids 
but "~<vas due pr·obably to diffusion through oily substances 
normally present in the skin. 
In contrast to these studies, Simon (17) performed 
experiments of the same nature and his results indicat~d 
0 
0 
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that the route of distribution of the allergen was not 
confined to the epidermis. He destroyed-an area of skin, 
by application of nitric acid, circling the middle of a 
guinea pig·and fomLd that sensitization of the skin of 
the hind end of ·the guinea pig resulted in sensitivity 
of the front end of the guinea pig as well as the hind end. 
Furthermore, he added that it took eighteeh to twenty-
four hours for the allergen to be absorbed from the 
skin because removal of the entire thickness of·skin, 
~ 
to vfhich the e.llergen had been ap,•lied, before eighteen 
to twenty-four hours prevented the development of 
sensitization: 
In basically similar experiments, these investigators 
1 
(cited above) obtained contradictory results as to how 
the allergen complex is transported. However, Haxthausen (32) 
presented evidence that generalized sensitization 
occurred because of systemic di-stribution of the allergen 
and not by extension through the epidermis. He transplanted 
sensitive skin of one identical ti.Yin to the other non-
sensitive member of the pair and vice versa. He found 
that sensitive skin in the nonsensitive individual soon 
lost, its sensitivity and the nonsensitive individual 
did not produce generalized skin sensitivity from.the 
transplant. Conversely, the nonsensitive graft in the 
sensitive individual soon acquired sensitivi.ty. He 
concluded that se~sitivity was not spread through the 
skin but by some other internal route. 
Evidence in support of t 1'le systemic distribution of 
0 
0 
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allergen as a means of obtaining generalized skin sensitivity 
also \rf~s presented by Landsteiner and Chase ( 38). They 
sensitized an area of skin of guinea pigs with poison 
ivy extract and then cut around this area leaving a 
sensitized island. They found that cutting the skin did 
not interfere with development of generalized skin sensitivity. 
Hm·rever, they extended their experiments by cutting away 
skin and muscle around the sensitized area. This prevented 
sensitization from occurring on other areas of the body. 
They attributed this to destruction of lymphatics which 
were a pathway for distribution of the allergen. 
Rostenberg (39) conducted a number of studies to 
determine the route the allergen takes after leaving 
the skin. In a revievr of the subject he stated that 
the lymph was the probable means of transfer of the 
allergen. Later, in 1947, he (33) reported experiments 
from which he concluded that there were many routes of 
passage of the allergen from the skin leading to 
generalization of sensitization. The lymph was probably 
the main means of transmission of the aller·gen but that 
generelized sensitization could occur even though l~nph 
channels were severed and that this was due to transfer 
of the allergen by the prickle cell bridges of epidermal 
cells and blood. This view was supported by others (28). 
Presence of Antibodies 
It has been proposed that the allergen is absorbed 
from the skin and transported in the body by means of 
the lymph, blood and prickle cell bridges of the epidermis. 
17. 
The place to which the allergen is transported is not 
knovm, however, it is generally assumed that this is 
the site of antibody production in the body and here 
the allergen provokes the formation of antibodies (40)(17). 
The antibodies produced are not of the conventional 
circulating type which react in vitro in serological 
tests, and these antibodies have been very difficult to 
detect (41). Because of this elusive nature of the 
antibody involved in allergic dermatitis, investigators 
have turned to use' of the Prausnitz-Kuestner Reaction 
which has become a powerful tool in diagnosis and 
study of atopic allergy. These exp?rimenters have 
attempted to passively sensitize nonsensitive subjects 
by injecting them with various tissues and fluids from 
sensitive persons. The classical method of performing 
the passive transfer test by injection of serum or plasma 
from a sensitive individual into a nonsensitive subject 
has been unsuccessful in numerous attempts to transfer 
sensitivity in allergic dermatitis. ~~~ 
One of the basic studies .of passive transfer was 
conducted by Grolnick (42) who set out to determine 
whether or not the antibodies in allergic dermatitis 
were passively transferred through the placenta. He 
sensitized seven pregnant women to krameria and found 
r 
that none of the babies born Qf these women reacted to 
krameria in a patch test. Therefore, he concluded that 
antibodies of allergic dermatitis were not passed through 
the placenta to the fetus. This finding was confirmed 
by the work of Straus (5) who showed that all newborn 
18. 
infants tested were nonsensitive to poison ivy extract. 
In 1942, Landsteiner and Chase (43) reported the 
first successful transfer of cutaneous sensitivity to 
picryl chloride in guinea pigs. This was done by intra-
peritoneal injection of peritoneal exudates from sensitized 
animals into nonsensitive animals. These guinea pigs 
developed sensitivity to picryl chloride in two days 
following injection. This sensitivity lasted a few days 
then faded indicating passive not active.sensitization. 
In addition, they discovered that t'~e cells of the exudate 
were necessary for this transfer because neither serum 
nor clarified supernatant fluid of the exudate were 
capable of transmitting the sensitivity. However, heating 
the exudate abolished the capability of passive sensitization. 
This work was extended by Chase (44) who stated 
that he had passively transferred sensitivity to picryl 
chloride, 2:4 dinitrochlorobenzene and o-chlorobenzene 
by cells from exudates, splenic pulp or lymph nodes of 
sensitized guinea pigs. He, too, mentioned that cells 
subjected to freezing or heatin3 were not effective in 
the passive transfer of the sensitivity. 
Later, Haxthausen (32) reported passive transfer of 
sensitivity to dinitrochlorobenzene by transfer of ground 
thymus gland of sensitive guinea pigs. He concluded that 
lymphocytes were carriers of the sensitizing antibody since 
most'cells of the thymus gland were lymphocytes and since 
granulocytes were not capable of tr~nsmitting sensitization. 
This conclusion also accounts for results of previous 
0 
0 
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investigators. 
This antibody seemed different from the preformed 
circulating R.ntibodies usually foul1.d in the blood 
serum because freezing or heating to such a degree 
that would not destroy preformed antibody did, in fact, 
destroy the passive sensitizing effect of these lymphocytes. 
The sensitizing effect of these lymphocytes was destroyed 
by any treatment which was·not compatible with the 
viability of the lymphocytes. Haxthausen (32) was un-
successful in his studies to determine the way in which 
this sensitizing effect was transmitted from the lym~hocytes 
to the cells of the skin. He found th~t local passive 
transfer vias not successful. He concluded his -work by 
posing the question of whether the lymphocytes themselves 
have this effect or whether they act only as carriers. 
Following successful passive transfer of sensitivity 
in experimental animals, experiments were aone in the 
hope of accomplishi~g the same thing in man. In 1952, 
Haxthausen (45) tried intracutaneous injections of 
leukocytes from s~nsitized individuals into nonsensitive 
persons. In his words, 11 The results of si:xty-six passive 
transfer experiments turned out perfectly :negative. 11 • 
In similar studies, Baer, Serri, and Kirman (46) 
attempted passive transfer by injecting plasma suspensions 
of viable white cells from sixty-six sensitive donors 
into sixty-six nonsensitive individuals. Of the receipients, 
20. 
sixty-t1·ro of the sixty-six people tested produced negative 
pe.tch tests to the specific sensi tizin¢ e.gent. 
Baer and Sulzberger (47) found essential1y the same 
results vrhen they took the _rrhite blood cel'ls from 
120 milliliters of blood from sensitive patients and 
injected them into the skin of twenty-seven nonsensitive 
persons. Ty.renty-three of these people, upon subsequent 
patch tests to the area 1·rhere the vrhi te blood cells had 
been injected, shovred no evidence of' having; received 
passive sensitization. It was noted that the four people 
who did show sensitivity to the patch tests retained 
their sensitivity for a long peri~d of time indicating 
active sensitization rather th~n a passive sensitivity. 
Furthermore, passive transfer of sensitivity from 
sensitive hu~ans to nonsensitive guinea pigs was 
unsuccessful. This was attempted by Rosentha.l, Litt and 
Baer (48) by intraperitoneal injection into guinea pigs 
of white blood cells from cen0itive persons. 
T~en, in 1957, Epstein and Kligman (49) reported 
successful transfer of sensitivity from man to man. 
They stated that transfer of sensitivity in humans depended 
Upon the extreme sensitivity of the donor, the large 
number of cells required, the nature of the allergen, 
and the receipient. It was noteworthy that at least 
170 million lymphocytes, equivalent to 150 to 200 milli-
liters of blood, were required for transfer of dinitro-
chlorobenzene sensitivity in man. 
Experiments of passive transfer produced by intra-
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cutaneous injection of fluid from the blisters of the 
lesions of allergic dermatitis have been attempted many 
times. In the pe.st, this procedure (50), called the 
Urbach-Koenigstein Tech~ique, has been used and results 
obtained "l;vere very irregular. It is now recognized 
th~t the fluids of these blisters contain a great many 
leukocytes which were responsible for the positive results 
obtained on passive transfer of the blister fluid. It 
appeared entirely possible that one of t'1e principle 
reasons for Dositive or negative results obtained with 
this test may huve been due to the presence or absence 
of viable leukocytes retained in the injection into the 
nonsensitive animal. 
Since all the vrork on passive transfer of sensi ti vi ty 
of allergic dermatitis indicated that the lymphocytes 
played a major role in transport of the antibody, it 
seemed reasonable to assume that interference with the 
functioning of lymphoid tissue would directly affect the 
sensitive state of allerGic dermatitis. This hypothesis 
was tested in 1951 by Cohen, Mayer and Griep (51). 
These investi3ators sensitized guinea pigs to paraphenylene-
diamine and then ~-rayed each animal with 175 r. This 
dose of irradiation did not completely destroy the lymphoid 
tissue. Subsequent testing by external anulication of 
~ ten per cent paraphenylenediamine ointment to the skin 
demonstrated an attenuation of the degree of skin sensitivity 
in the irradiated animals as comp?red to non-irradiated 
controls. However, in another group of guinea pigs 
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treated in the same manner, subsequent testing was done 
by intradermal injection of the sensitizing substance 
and the results were no different between irradiated and 
non-irradiated animals. The variation of results among 
these experimental groups was unexplained. 
Further work along the same lines was carried out 
by Rostenberg, McOrarey and Bluefarle {52) in 1956. 
They found that patients with a lymphoma-leukemia disease 
did not possess the ability to develop sensitivity to 
simple chemicals as readily as control groups of patients 
with other chronic illnesses. These workers belieYed 
that this impairment occurred as a direct result of the 
lymphoblastomatous disease process on the cells of the 
lymphoreticular system which are c6ncerned with production 
of antibody. They proposed further investigation into 
these reactions. 
Function of Allergen in the Body 
The role of the allergen in the body presumably is 
to stimulate the production of antibodies, although there 
is no demonstrable antibody in sensitized subjects by 
conventional serological tests. Nevertheless,. the ability 
to passively transfer sensitization indicates that a 
substance similar to antibodY- must be present. Furthermore, 
primary exposure of an individual to an allergen requires 
~ a period of ten to fourteen days for sensitivity to· 
develop a~1d the same allergen is required to evoke the 
allergic reaction. These conditions are the same 
requirements for the conventional antigen antibody reactions. 
Few investigators question that the mechanism involved 
in allergic dermatitis has an antigen antibody basis. 
--
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As with all other antigen antibody systems, neither the 
site nor the mechanism of antibody prod~ction is definitely 
established. A few investigators have advanced theories 
to account for the formation of antibody in allergic 
dermat it ia. 
Rostenberg (53), Rostenberg and Brunner (54) and 
Rostenberg and Best· (55) proposed that the antigen complexed 
1-ri th protein is picked up by macrophages. The antigen is 
transported-by way of lymphatics and blood to the hemato-
poietic and reticulo-endothelial systems. Here, it 
causes enzymatic adaptation to occur in the primitive 
reticulum cells. The enzymes of the primitive reticulum 
cells become adapted to the antigen and the result is a 
specific alteration in the product produced by these 
enzymes. This adaptation is believed to be pas~ed on to 
descendents of the primitive reticulum cells. The cells 
in which this adaptation has occurred respond differantly, 
from the normal, upon subsequen~ enco~ters with the antigen. 
Epstein (56) has set forth another hypothesis of 
the antigen antibody reaction in allergic dermatitis. 
The usual concept of the antigen in allergic dermatitis 
is that the simple chemical (hapten) portion of the 
complex confers·specificity upon the allergen while the 
protein portion of t1le complex merely acts as a carrier. 
Epstein has suggeste~ that the protein portion, normally 
from the skin, by its action with the hapten is altered 
in such a way as to have an antigenic effect itself. 
• 
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He has called this protein portion a "protigen". Both 
the hapten and the 11 protigen11 possibly provoke antibody 
production which is believed to take place in lymphatic 
tissue. Therefore, the allergic reaction might be 
elicited not only by exposure to the simple chemical 
substance but also by substances which might be liberated 
from the skin. This theory explains several observations 
characteristic of allergic dermatitis. 
Still another theory was published by Everall and 
Truter ·(57). This approach is based upon an assumption 
that there are "neutralizers" present in the body which 
function to remove foreign substa,nces. When the foreign 
substances reach such proportions as to outnumber the 
"neutralizers", the threshold is lm"l-ered and sensitivity 
develops. "Neutralizers 11 are said not to be found in 
plasma, or serum but may be associated with lymphocytes. 
Protection against Sensitizing Agents 
Many efforts have been made to establish some means 
by which people could develo~ protection against sensitizing 
agents. Epstein an-l Claiborne (58) observed that people 
of the oriental race who were born in the orient but 
subsequently came to this country were less sensitive 
to poison ivy than persons of the same race born in this 
country. They prnposed that this decreased sensitivity 
-
was due to a developed immunity arising from environmental 
factors. It had been thought that early exposure to 
pl8nts (Rhus) related to the poison ivy plant in childhood 
developed this lasting immunity. 
0 
With such a protective mechanism in mind, numerous 
attempts have been made to prevent sensitization or to 
desensitize by a long continuous exposure to the sensitizing 
agent. In 1946, Chase (59) found that feeding a one 
per cent solution of 2:4 dinitrochlorobenzene to guinea 
pigs inhibited the development of sensitivity. This 
inhibition was specific and did not affect the capacity 
of the animal to become sensitive to other allergens. 
In these experiments, the duration of protection was 
measured only to the twenty-seventh v-reek after exposure. 
Shelmire (60) hyposensitized an individual to poison 
ivy by massive ora.l doses of the oleoresin over a 
period of ten months. On the other hand, he was not 
able to desensitize several individuals sensitized to 
krameria by feeding them the antigen. Grolnick (61) was 
equally unsuccessful in desensitizing humans by oral 
administration of tincture of krameria. Kligman (11) 
fed an alcoholic extract of poison ivy to children and 
noted no protection against sensitization to the specific 
agent. He proposed that success of such studies depended 
upon whether experimental animals or human subjects were 
used. Results in animals were more favorable than with 
human subjects. It was his opinion that the successful 
prevention of sensitization could only be explained either 
t:) by an immunological mechanism or a blocking pharmacological 
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property which interfered with the sensitizing :process •. 
~ Recently, such a mechanism has been described by Epstein 
f • 
and Kligman (62). These investig,ators applied two 
unrelated sensitizing substances simultaneously to 
separate skin sites. It was noted t~at sensitization 
I 
occurred to only one agent and not to both. Sensitivity 
did not develop to the other allergen for about two 1'/"eeks 
. . 
after the initial application of th~ subst~nce to the 
skin. Apparently, the more potent all.ergen wes uapable 
of blocking sensi ti vi ty to the vTealter 13gent. Tl'lis 
i~terference phenomenon has yet to be explained, although 
similar experiments have been reported long ago rli th 
the influenza virus and related viruses. 
Oral, topical and parenteral (63)(11) routes of 
administration of sensitizing agents have been used 
repeatedly in an effort to protect against aensitization 
in humans. Although these attempts have been unsuccessful, 
occasional spontaneous loss of sensitivity has been 
reported (12). Kanqf and Rostenberg (9) cnducted a study 
on 66 people (average age of 47.8 years) who were incarcerated 
for an average period of eleven years. Fifteen and 
one-half per cent of ti'J.ese people itrere shown to be sensitive 
to a 1:100 dilution of poison ivy extract as opposed 
to twenty-five per cent of a control group (average age 
of 44.5 years) of 48 people. This indicated that, 
although sensitivity did persist, there was a decrease 
in the incidence of sensitivity among people who were not 
in contact with the plant for a number of years. 
In contrast, desensitization of persons wit~ allergic 
dermatitis has been encountered frequently in industry. 
Continually, people in industry have become sensitized 
to industrial products. A large number of these individuals 
have been known to become desensitized by the process 
commonly referred to as 11 hardening11 (28). This process 
is merely a repeated exposure to the.agent which has 
induced the sensitization. There develops a resultant 
lessening of the sensitive reaction. The aforementioned 
experimental studies of topical and parenteral administration 
of allergen did not shed light ~s to the nature of this 
reaction. At present, it is not known ·ho~r this 11 hardening11 
process takes place. 
Substances Capable of Provoking the Reaction 
The reaction of allergic dermatitis in sensitiye 
individuals can be brought about by application to the 
skin of the specific substance which caused the sensitivity 
to develop. This fact is one of the basic characteristics 
of allergic dermatitis and one of the main reasons why 
it is generally felt that this is an antigen antibody reaction. 
Besides provocation of the reaction by the specific 
allergen, it has been found thRt the reaction, in some 
instances, could be elicited by chemically related substances 
to the sensitizing agent. This has come to be known as 
cross-sensitization. A great many studies have been 
conducted on the nature and action of substances involved 
28. 
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in cross-sensitization. It w~s felt by Epstein (56) that 
cross-sensitivity was due to the presence of a particular 
chemical group or grouping of the sensitizing substance. 
Sensitization then, brought about the production of anti-
bodies which would react with various chemicals having 
the same chemical grouping. Rostenberg and Kanof .(64) 
proposed three possible requirements for cross-sensitivity. 
These were: 1. structural similarity of the compounds, 
2. conjugation of the cross-sensitizing compound with 
protein in the same way as the original sensitizing 
agent, 3· breaking down of the sensitizing allergen 
by the body so that sensitization-occurred to some degradation 
product and the cross-sensitizing substance was metabolized 
to yield the same product. In experiments performed with 
halo benzenes, Rostenberg and Kanof found that the ability 
of a substance to conjugate with the protein was not the 
prime factor in determining whether or not a substituted 
halo benzene was capable of causing a,cross reaction in 
a sensitive individual to another halo benzene. But, 
moreover, in tests of six structural isomers of substituted 
benzenes, they concluded that the order of reactions 
seemed to parallel the order of closeness of geometric 
resemblance to the original compound. 
Numerous chemicals have been tested for their ability 
to elicit the allergic dermatitis reaction.by cross-
sensitization. This subject has been adequately reviewed 
by Baer (65) and Wagner (66). Cross-sensitization has 
been found to occur frequently among cert~in local 
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anesthetics and sulfonamide drugs, local anesthetics 
and paraphenylenediamine, certain derivatives of 
nitrobenzene and of aniline, paraphenylenediamine and 
azodyes, and many more. 
It has been found that substances which cause the 
state of delayed hypersensitivity by sensitization 
through the skin could also cause an immediate type of 
hypersensitivity if the agent were injected intravenously 
in an already sensitized animal. This h2s been found to 
occur (67) among certain substances giving rise to the 
typical allergic dermatitis. The importance of this 
finding lies in the administretion of drugs, particularly 
sulfonamides or local anesthetics, to sensitive individuals (68). 
Even more important is the apparent reactivity to the 
substances on seemingly first contact which is truly a 
cross-sensitization. Fatalities have been reported (69)(70) 
due to glomerulonephritis which occurred in persons 
with poison ivy sensitivity who were given injections of 
extracts of poison ivy in an effort to desensitize the 
-individuals. 
The spontaneous flare-up phenomenon has been referred 
to numerous ti1nes in the literature. It consists (71) 
of the reaction of allergic dermatitis occurring about 
seven to twenty-four days after appli~ation of the allergen 
to the skin of a nonsensitive individual. Grolnick (72) 
has found this to be due to remaining antigen fixed 
to the skin. Persons who h8d several patch tests before 
the flare-up occurred were found to react to the most 
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recent site of application of t~e allergen, then reactions 
occurred at sites of other apnlications in order of the 
most recent to the oldest test site. This 1'ras found to 
be due to t'1.e concentr<?.tion of antigen which remained at 
the test sites. It was noticed by \Vhite and Baer (73) 
that of 124 patients who received subsensitizing doses 
of dinitrochlorobenzene, 70 developed a flare up reaction 
at these test sites when they aubsequently were subjected 
to sensitizing doses of this allergen. 
Further·more, Grolnick ( 7 4) reported his observa.tions 
that healed sites of the reaction of allergic dermatitis 
were more reactive and responsive to another unrelated 
allergen than was the norm:?.l skin of the seme person. 
This vras also found by Sulzberger and Rostenberg ( 75) 
who stated that people with allergic. dermatitis were twice 
as susceptible to sensitization with another specific 
substance tltan 'tvere people irTi th normal skin who had never 
had allergic dermatitis. 
Nature of Action Between Sensitized Cells and Allergen 
The process of sensitization, by some unknown mechanism, 
imparts to the skin the capacity to react upon exposure 
to the specific allergen. It has been shown by Shelmire (76) 
that this exposure of the allergen to t~e skin need occur 
for only one minute for the rer-:cti-on to manifest itself. 
Apnarently the allergen unites ·with the sensitive cell, 
or some part of it, immediately upon contact. The lesion 
appears usually between twenty-~our and forty-eight hours 
later. 
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Dienes (77) studied the response of t~e sensitive 
tissue to the allergen and stated that the process affects 
the epidermis mainly and the immediate underlying layer 
of the derma. Although most investigators (71) believe 
the reaction ·is limited to the £kin, some evidence has 
appeared (18) that the mucous membrane adjacent to skin 
is Plso reactive. 
Histology of the lesions of allergic dermatitis has 
been studied and described many times (17)(71)(78)(79)(80). 
Within one or two hours after contact with the allergen, 
there appears vasodilatation and edema of the corium. 
There is some dispute as to whether this reaction is 
initiated in the epidermis. or the corium. Nevertheless, 
the first discernible changes are alteration of individual 
prickle cells and epidermal edema. This leads to spongiosis 
and formation of the 11 primordial vesicle 11 "\'Then the damaged 
cell is dissolved. Following this, the overstretched 
intercellular bridges rupture and intra-e~idermal 
vesicles result. There is a regenerative effort of basal 
cells formin~ new cells. Because of this, the epidermis 
is hyperplastic and the demaged tissue is pushed outward. 
The edematous strata undergo an accelerated process of 
faulty keratinization _in which there is n'o disappearance 
of nuclei. At this time, inflammatory cells, leukocytes, 
~ and lymphocytes invade the epidermis in great numbers. 
The upuer corium is edematous and from dilated blood 
capillaries many lymphocytes infiltrate the area and into 
the epidermis. Eosinophile are present. 
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The reaction of allergic derm~titis has been described 
many times as being indistinguishable from lesions of the 
skin caused by primary irritants. However, histologically, 
the lesions differ (80) in that the main infiltrating 
cell in primary irritant lesions is the polymorphonuclear 
neutrophil, whereas, the infiltrating cell of allergic 
dermatltis is the lymphocyte. Smears of exudates from 
the lesions of allergic dermatitis have been found to 
contain (81)(63) an abundance of mononuclear cells. In 
contrast, the lesions of primary irritants are filled 
with polymorphonuclear neutrophils. 
Rostenberg (19)(53) has made studies on the lesion 
of allergic dermatitis and from the type of lesion produced 
he concluded that the mechanism of action of the specific 
antigen antibody system is to interfere with the pyruvate 
oxidase enzyme system of the cells and to inhibit hexokinase 
activity at the epidermal-dermal junction. It was shown 
that chemical agents which inhibit these enzyme activities 
are vesiculating agents. 
Generalized physical findings (82) in patients with 
allergic dermatitis are usually normal with exception of 
the skin lesions just described. It, therefore, appears 
that the shock tissue in this type of hypersensitivity 
is the skin. 
• 
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Conclusions 
Up to the present time, researchers have contributed 
a great deal to the understanding of the immunological 
mechanism of allergic dermatitis. Yet, many aspects of 
this reaction remain obscure. The conclusions that can 
be drawn portray the process of sensitization, and its 
related factors, in the· ~allowing sequence. 
Throughout the years, many studies have been conducted 
on various groups of people in order to determine the 
per cent of normal populations possessing the capacity 
to become sensitive to various allergenic substances. The 
outcome of these studies was that the incidence of 
sensitization of a given population varied with the nature 
of the allergen, the concentration of the allergen, the 
species of the host, the environmental influences on 
the host, the age of the host, and finally, the genetic 
make-up of the host. Apparently, all of these factors 
interact to determine the capacity of an individual to 
become sensitized. 
Numerous substances have been shown to be capable 
of sensitizing the skin of man or experimental animals. 
These substances can be simple chemical compounds which 
by themselves are not antigenic w~en introduced into 
the body by means other than the cutaneous route. 
However, when these simple chemical agents are applied 
to the skin, they combine chemically with proteins o~ 
the epidermis and are absorbed from the skin in this 
form. 
The route of absorption of the allergen combined 
to the protein has been the subject of many ingenious 
investigations and the to~ic of heated debates because 
different experimenters arrived at different conclusions 
from their investigations. The most widely accepted 
view today is that the combined allergen is absorbed 
from the skin by the lymph, blood, and prickle cell 
bridges of the epidermal cells. This manifold means 
of transmission of t~e allergen probably accounts for 
the differing reports in the literature of various 
investigators. 
It is generally accepted that the allergen is trans-
ported to the portion of the body concerned with antibody 
production. Here, specific antibodies are produced which 
a.re not of the normal circulating type. Several theories 
have been proposed to account for this particular type 
of antibody production but no direct proof is available 
at the present time. 
The antibody, once formed, in some way is transported 
and released to the epidermal cells, since reactions of 
allergic dermatitis take place almost exclusively in 
the skin. There is indirect evidence in the literature 
that this means of transport of the antibody is the 
lymphocyte since passive transfer of the sensitivity 
can be ·effected by transfer of large numbers of lymphocytes 
from a sensitized individual. 
Efforts have been made to immunologically block 
the process of s.ensi tization. Most of these attempts 
have been unsuccessful. However, an interference phenomenon 
has recently been observed in which sensitization to 
an allergen is inhibited by simultaneous application of 
another potent allergen. 
Once sensitivity is established, an individual 
manifests the allergic reaction upon subsequent exposure 
to the same substance which caused the sensitivity to 
develop. This specificity accounts for the general 
belief that allergic dermatitis is based upon an antigen 
antibody interaction. It has been noted that chemical 
agents possessing structural formulas very similar to 
the structure of the allergen which caused sensitivity 
to'develop may elicit the allergic reaction in that 
individual upon first exposur-e. This is called cross-
sensitization and because of the simila.rity of structural 
formulas of many synthetic chemicals used in industry, 
this cross-sensitization has become a real problem. 
Provocation of the sensitive reaction in an allergic 
person is accompanied by definite histologic changes 
of the epidermis and underlying corium. This reaction 
is manifested by marked inflammation of the skin with 
formation of vesicles. 
Research in the field of allergic dermatitis ap1:>ears 
inviting and challenging. There is still a great deal 
3b· 
needed to be done to uncover the basic mechanisms of 
antigen antibody interaction. A full understanding of 
this reaction is needed in order to control the increa-sing 
occurrence of sensitivity to synthetic.chemicals. It 
is the author's opinion that investigations int_o the 
j 
nature and action of the antibody by means of the 
flourescin labeled antibody technique might prove 
rewarding. This approach has not been used, to the 
knowledge of the author, in studies of allergic dermatitis. 
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